Table 1.
Body weight of sub-chronic group rats from control and PHF administered for 28 days.
| Weeks | Sex | Weight in grams |
P value | ||
|---|---|---|---|---|---|
| Control (No dose) | PHF |
||||
| 500 mg/kg body weight | 1000 mg/kg body weight | ||||
| Baseline | M (n = 3) | 199.10 ± 38.87 | 218.33 ± 22.54 | 255.33 ± 17.24 | |
| F (n = 3) | 205.50 ± 9.19 | 211.33 ± 11.84 | 215.11 ± 3.00 | ||
| T (n = 6) | 201.30 ± 22.60 | 214.80 ± 16.54 | 235.13 ± 24.70 | P = 0.058 | |
| Week 1 | M (n = 3) | 204.33 ± 32.31 | 213.33 ± 22.3 | 250 ± 21.79 | |
| F (n = 3) | 208.00 ± 10.81 | 207.13 ± 7.20 | 215.50 ± 8.66 | ||
| T (n = 6) | 206.10 ± 21.60 | 210.1 ± 15.20 | 232.50 ± 24.21 | P = 0.091 | |
| Week 2 | M (n = 3) | 211.66 ± 25.65 | 215.66 ± 24.37 | 247.10 ± 18.24 | |
| F (n = 3) | 211.33 ± 20.25 | 206.66 ± 16.07 | 214.33 ± 14.36 | ||
| T (n = 6) | 211.51 ± 20.60 | 211.10 ± 19.12 | 230.60 ± 23.12 | P = 0.218 | |
| Week 3 | M (n = 3) | 206.66 ± 25.4 | 218.33 ± 25.65 | 242.10 ± 7.54 | |
| F (n = 3) | 215.33 ± 16.16 | 203.33 ± 12.58 | 212.40 ± 15.71 | ||
| T (n = 6) | 211.20 ± 19.60 | 210.80 ± 19.80 | 227.80 ± 19.74 | P = 0.295 | |
| Week 4 | M (n = 3) | 212.40 ± 17.52 | 212.33 ± 33.23 | 227.66 ± 15.94 | |
| F (n = 3) | 232.66 ± 17.03 | 196.66 ± 6.65 | 213.33 ± 10.06 | ||
| T (n = 6) | 222.34 ± 19.10 | 204.52 ± 23.10 | 220.5 ± 14.24 | P = 0.240 | |
Values expressed as mean ± SD. Significance with One way ANOVA analysis is evaluated as p ≤ 0.05. Note: F – female, M− male, T – total.